We are live on ! Find out more
ETNB

89bio

Delisted

ETNB was delisted on the 29th of October, 2025.

70 hedge funds and large institutions have $92.8M invested in 89bio in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

75.61% more ownership

Funds ownership: 83.87%159.48% (+76%)

44% more capital invested

Capital invested by funds: $64.3M → $92.8M (+$28.5M)

1% more funds holding

Funds holding: 6970 (+1)

9% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 23

Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
26
Reduced
14
Closed
23
Calls
$761K
Puts
Net Calls
+$761K
Net Calls Change
+$454K
Name Holding Trade Value Shares
Change
Change in
Stake
OQS
51
Occudo Quantitative Strategies
Florida
$86K +$30.9K +10,234 +62%
CSS
52
Cubist Systematic Strategies
Connecticut
$82K +$19.4K +6,410 +34%
Barclays
53
Barclays
United Kingdom
$79K +$8.81K +2,920 +14%
VF
54
Virtu Financial
New York
$65K +$61K +20,222 New
Simplex Trading
55
Simplex Trading
Illinois
$64K +$60.1K +19,912 +13,732%
RJA
56
Raymond James & Associates
Florida
$63K +$58.9K +19,507 New
PP
57
PDT Partners
New York
$33K -$39.5K -13,099 -56%
PMAM
58
Penn Mutual Asset Management
Pennsylvania
$33K
Squarepoint
59
Squarepoint
New York
$33K +$31.2K +10,348 New
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$15K -$92.4K -30,606 -87%
O
61
OrbiMed
New York
$11.8K
Fidelity Investments
62
Fidelity Investments
Massachusetts
$7K -$2.14M -710,131 -100%
TRCT
63
Tower Research Capital (TRC)
New York
$7K -$4.33K -1,434 -38%
Federated Hermes
64
Federated Hermes
Pennsylvania
$3K -$1.04K -345 -26%
Rockefeller Capital Management
65
Rockefeller Capital Management
New York
$3K
CAL
66
Capital Advisors Ltd
Ohio
$3K +$2.41K +798 New
Osaic Holdings
67
Osaic Holdings
Arizona
$1K +$851 +282 New
Wellington Management Group
68
Wellington Management Group
Massachusetts
-$6.72M -1,782,053 Closed
Franklin Resources
69
Franklin Resources
California
-$1.58M -419,560 Closed
GCP
70
GSA Capital Partners
United Kingdom
-$350K -92,815 Closed
XT
71
XTX Topco
Cayman Islands
-$178K -47,147 Closed
N
72
Nuveen
North Carolina
-$149K -38,906 Closed
Public Employees Retirement Association of Colorado
73
Public Employees Retirement Association of Colorado
Colorado
-$121K -32,154 Closed
Bank of New York Mellon
74
Bank of New York Mellon
New York
-$116K -30,632 Closed
TI
75
Trexquant Investment
Connecticut
-$100K -26,433 Closed

ETNB Hedge Fund Activity: Q2 2022 in Review

70 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q2 2022, worth a combined $92.8M — up 44% from $64.3M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ETNB positions and 23 closed out — a net gain of 2 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $11.8M. The largest seller was Wellington Management Group, exiting entirely with an estimated $6.72M sold.

  • 70 institutional investors held 89bio (ETNB) as of Q2 2022, up from 69 in Q1 2022.
  • Funds reported $92.8M of 89bio stock for Q2 2022, up 44% quarter-over-quarter.
  • 25 funds opened new 89bio positions in Q2 2022 and 23 closed out, a net change of +2 holders.
  • The largest 89bio buyer in Q2 2022 was BVF Inc, an estimated $11.8M added.
  • The largest 89bio seller in Q2 2022 was Wellington Management Group, an estimated $6.72M sold.

Based on aggregated 13F filings for Q2 2022.